Literature DB >> 29206046

Hydrophobic Ion Pairing of Peptide Antibiotics for Processing into Controlled Release Nanocarrier Formulations.

Hoang D Lu1, Paradorn Rummaneethorn1, Kurt D Ristroph1, Robert K Prud'homme1.   

Abstract

Nanoprecipitation of active pharmaceutical ingredients (APIs) to form nanocarriers (NCs) is an attractive method of producing formulations with improved stability and biological efficacies. However, nanoprecipitation techniques have not been demonstrated for highly soluble peptide therapeutics. We here present a model and technique to encapsulate highly water-soluble biologic APIs by manipulating API salt forms. APIs are ion paired with hydrophobic counterions to produce new API salts that exhibit altered solubilities suitable for nanoprecipitation processing. The governing rules of ion pair identity and processing conditions required for successful encapsulation are experimentally determined and assessed with theoretical models. Successful NC formation for the antibiotic polymyxin B requires hydrophobicity of the ion pair acid to be greater than logP = 2 for strong acids and greater than logP = 8 for weak acids. Oleic acid with a logP = 8, and pKa = 5, appears to be a prime candidate as an ion pair agent since it is biocompatible and forms excellent ion pair complexes. NC formation from preformed, organic soluble ion pairs is compared to in situ ion pairs where NCs are made in a single precipitation step. NC properties, such as stability and release rates, can be tuned by varying ion pair molecular structure and ion pair-to-API molar ratios. For polymyxin B, NCs ≈ 100-200 nm in size, displaying API release rates over 3 days, were produced. This work demonstrates a new approach that enables the formation of nanoparticles from previously intractable compounds.

Entities:  

Keywords:  antibiotics; controlled release; hydrophobic ion pairing; nanocarrier

Mesh:

Substances:

Year:  2017        PMID: 29206046     DOI: 10.1021/acs.molpharmaceut.7b00824

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Encapsulation of OZ439 into Nanoparticles for Supersaturated Drug Release in Oral Malaria Therapy.

Authors:  Hoang D Lu; Kurt D Ristroph; Ellen L K Dobrijevic; Jie Feng; Simon A McManus; Yingyue Zhang; William D Mulhearn; Hanu Ramachandruni; Anil Patel; Robert K Prud'homme
Journal:  ACS Infect Dis       Date:  2018-04-12       Impact factor: 5.084

Review 2.  Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers.

Authors:  Kurt D Ristroph; Robert K Prud'homme
Journal:  Nanoscale Adv       Date:  2019-10-01

3.  Dual-Acting Zeta-Potential-Changing Micelles for Optimal Mucus Diffusion and Enhanced Cellular Uptake after Oral Delivery.

Authors:  Ahmad Malkawi; Nasr Alrabadi; Ross Allan Kennedy
Journal:  Pharmaceutics       Date:  2021-06-27       Impact factor: 6.321

4.  Design and optimization of metformin hydrophobic ion pairs for efficient encapsulation in polymeric drug carriers.

Authors:  Sara I Abd-El Hafeez; Nermin E Eleraky; Ehsan Hafez; Sara A Abouelmagd
Journal:  Sci Rep       Date:  2022-04-06       Impact factor: 4.379

5.  API ionic liquids: probing the effect of counterion structure on physical form and lipid solubility.

Authors:  Leigh Ford; Erin Tay; Tri-Hung Nguyen; Hywel D Williams; Hassan Benameur; Peter J Scammells; Christopher J H Porter
Journal:  RSC Adv       Date:  2020-03-31       Impact factor: 4.036

6.  Self-Emulsifying Drug Delivery Systems: Hydrophobic Drug Polymer Complexes Provide a Sustained Release in Vitro.

Authors:  Ahmad Malkawi; Aamir Jalil; Imran Nazir; Barbara Matuszczak; Ross Kennedy; Andreas Bernkop-Schnürch
Journal:  Mol Pharm       Date:  2020-09-05       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.